ABSTRACT
Breast hamartoma is a benign tumour consisting of fat, fibrous and glandular tissue. A young woman in her 19th week of pregnancy underwent exceptional surgery for a unilateral gigantomastia secondary to a rapid-growth giant hamartoma during her second pregnancy. Rigourous clinical and ultrasonographic examinations were performed followed by multiple biopsies. The decision to perform surgery was guided by the risk to skin integrity and of tumour infarct. Our report provides detailed information on gestational benign breast tumours, on the specificities of medical imaging and breast surgery in pregnant patients.
Subject(s)
Breast Diseases/complications , Breast/abnormalities , Hamartoma/complications , Hypertrophy/etiology , Pregnancy Complications/surgery , Adult , Breast/pathology , Breast Diseases/surgery , Female , Gestational Age , Hamartoma/surgery , Humans , Hypertrophy/diagnostic imaging , Hypertrophy/pathology , Pregnancy , UltrasonographyABSTRACT
Pap smear screening of women under 25 years old remains controversial. No randomized study exists on this topic. The perception of individual benefit often prevails, although there is no proof of effectiveness and no demonstrated risk-benefit ratio. A review of published studies - taking into account epidemiological data, effectiveness of screening of young women, adverse medical outcomes and costs - suggests that there are more arguments against screening before 25 than in favour of it.